In-Vitro Diagnostics (IVD) Market 2020 Analysis and Precise Outlook - Roche Holding AG, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc.

The report presents authentic and accurate research study on the global In-Vitro Diagnostics (IVD) Market on the basis of qualitative and quantitative assessment done by the leading industry experts. The report throws light on the present market scenario and how is it anticipated to change in the coming future. Growth determinants, micro and macroeconomic indicators, opportunities, developments, and key market trends are scrutinized in this report that are likely to have a major influence on the global In-Vitro Diagnostics (IVD) Market Growth.

The global IVD market value is forecasted to reach US$92.54 billion in 2023, growing at a CAGR of 6.6%, for the period spanning from 2018 to 2023.

Inquire for Sample Copy of this Report:
https://www.marketinsightsreports.com/reports/04282009300/global-in-vitro-diagnostics-ivd-market-report-insights-trends-and-forecast-2019-2023/inquiry?source=openpr&Mode=07

Market Overview:

The factors such as increasing diabetic patient count, surging chronic ailments incidence, rising healthcare expenditure, growing geriatric population, accelerating economic growth and improving consumer confidence are expected to drive the market growth. However, growth of the industry would be challenged by stringent regulations and intense competition. A few notable trends include development of syndromic panel, rising companion diagnostic tests preference by physicians, escalating research and development expenditures, applications of human microbiome in IVD, liquid biopsy for cancer testing and high IVD per capita expenditure in Europe.

The modern IVD industry comprises of three types of products namely; reagents, analytical instruments and accessory products that are required to perform an array of diagnostic laboratory tests and thereby helping the individual to monitor different types of diseases.

The fastest growing regional market is North America, owing to rise in incidence & prevalence of chronic diseases, technological advancements in testing techniques and the increase in healthcare expenditure by population. The U.S. represents one of the largest market for IVD and is already well-penetrated at developed market levels.

Scope of the report:

- The report provides a comprehensive analysis of the global IVD market, segmented on the basis of product types i.e. reagents, instrumentations & software services and technologies i.e. immunodiagnostics, POCT, microbiology, SMBG, molecular diagnostics & clinical chemistry.
- The major regional markets (North America, Asia-Pacific and Europe) have been analysed along with country coverage of the U.S., China, Japan, Australia, India, Germany, Italy and France.
- The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
- The competitive landscape of the market, along with the company profiles of leading players i.e. Roche Holding AG, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc. and Sysmex Corporation are also presented in detail.

Browse the report description and TOC:
https://www.marketinsightsreports.com/reports/04282009300/global-in-vitro-diagnostics-ivd-market-report-insights-trends-and-forecast-2019-2023?source=openpr&Mode=07

Latest Industry News:

Jan 22, 2020, NEW YORK - Japanese diagnostics firm Sysmex said on Wednesday that it has received Class III approval from China's National Medical Products Administration for its Lynoamp BC in vitro diagnostic reagent. According to Sysmex, the reagent is used for the detection of cytokeratin 19 mRNA in sentinel lymph nodes removed during breast cancer surgery in order to diagnose lymph node metastasis. It is designed to run on the company's RD-100 gene amplification detector system using a proprietary one-step nucleic acid amplification method. Results whether lymph node metastasis has occurred can be achieved within about 30 minutes using Sysmex's technology, the company said.

Basel, 13 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples from patients who meet COVID-19 clinical and/or epidemiological criteria for testing. Hospitals and reference laboratories can run the test on Roche's fully automated cobas 6800 and cobas 8800 Systems, which are widely available in the U.S. and around the world.

Key Target Audience:
- IVD Reagent/Instrument Manufacturers
- Raw Material/Component Suppliers
- End Users
- Consulting Firms
- Investment Banks
- Government Bodies & Regulating Authorities

Purchase Full Report (USD $1800):
https://www.marketinsightsreports.com/report/purchase/04282009300?mode=su?source=openpr&Mode=07

The Table of Contents
1. Market Overview

1.1 Introduction
1.2 IVD Product Types
1.3 IVD Tests
1.4 Classification of IVD Technologies
1.5 Application of IVD
1.6 IVD Value Chain Analysis

2. Global IVD Market Analysis

2.1 Global IVD Market Value Forecast
2.2 Global IVD Market Value by Product
2.2.1 Global Reagents Market Value Forecast
2.2.2 Global Instrumentation Market Value Forecast
2.2.3 Global Instrumentation Market Value by Segment
2.3 Global IVD Market Value by Technology
2.3.1 Global Immunodiagnostic Market Value Forecast
2.3.2 Global Immunodiagnostic Market Value by Indication
2.3.3 Global Self Monitoring Blood Glucose Market Value Forecast
2.3.4 Global Point-of-Care Market Value Forecast
2.3.5 Global Point-of-Care Market Value by Product
2.3.6 Global Chemical Chemistry Market Value Forecast
2.3.7 Global Molecular Diagnostic Market Value Forecast
2.3.8 Global Molecular Diagnostics Market Value by Indication
2.3.9 Global Hematology Market Value Forecast
2.3.10 Global Microbiology Market Forecast
2.4 Global IVD Market Value by End User
2.5 Global IVD Market Value by Region

3. Regional IVD Market Analysis

3.1 North America
3.1.1 North America IVD Market Value Forecast
3.1.2 North America IVD Market Value by Country
3.1.3 The U.S. IVD Market Value Forecast

3.2 Asia-Pacific
3.2.1 Asia-Pacific IVD Market Value Forecast
3.2.2 Asia-Pacific IVD Market Value by Country
3.2.3 China IVD Market Value Forecast
3.2.4 Japan IVD Market Value Forecast
3.2.5 Australia IVD Market Value Forecast
3.2.6 India IVD Market Value Forecast

3.3 Europe
3.3.1 Europe IVD Market Value Forecast
3.3.2 Europe IVD Market Value by Country
3.3.3 Germany IVD Market Value Forecast
3.3.4 Italy IVD Market Value Forecast
3.3.5 France IVD Market Value Forecast

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Increasing Diabetic Patient Count
4.1.2 Surging Chronic Ailments Incidence
4.1.3 Rising HealthCare Expenditure
4.1.4 Growing Geriatric Population
4.1.5 Accelerating Economic Growth
4.1.6 Improving Consumer Confidence

4.2 Key Trends and Developments
4.2.1 Development of Syndromic Panel
4.2.2 Rising Companion Diagnostic Tests Preference by Physicians
4.2.3 Escalating MedTech Research and Development Expenditures
4.2.4 Applications of Human Microbiome in IVD
4.2.5 Liquid Biopsy for Cancer Testing
4.2.6 High IVD per Capita Expenditure in Europe

4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Intense Competition

5. Competitive Landscape

5.1 Global IVD Market
5.1.1 Key Players - Market Share Comparison
5.1.2 Key Players - Revenue Comparison
5.1.3 Key Players - Market Cap Comparison
5.1.4 Key Players - Research & Development Expenditure Comparison
5.1.5 Key Players - Molecular Diagnostics Market Share Comparison
5.1.6 Key Players - Immunodiagnostics Market Share Comparison
5.1.7 Key Players - POCT Market Share Comparison

6. Company Profiles

6.1 Roche Holding AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 Abbott Laboratories
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 Danaher Corporation
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 Siemens AG
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

6.5 Thermo Fisher Scientific Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies

6.6 Sysmex Corporation
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.